AbbVie

Yahoo Finance • 10 hours ago

Assessing AbbVie (ABBV) Valuation After FDA Filing for New Parkinson’s Drug Tavapadon

If you have been following AbbVie (ABBV), the company’s latest move might sway your decision on whether to stick with or jump into the stock. AbbVie just submitted a New Drug Application to the FDA for tavapadon, its potential new treatmen... Full story

Yahoo Finance • 2 days ago

Stocks Finish Higher as Core PCE Prices Match Expectations

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Friday closed up +0.59%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/f... Full story

Yahoo Finance • 2 days ago

Stocks Climb on Strength in Consumer Spending and Tame Inflation

The S&P 500 Index ($SPX) (SPY) today is up +0.56%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.81%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.28%.  December E-mini S&P futures (ESZ25) are up +0.53%, and December E-mini Nas... Full story

Yahoo Finance • 2 days ago

Stocks Turn Mixed as US Consumer Sentiment Slips

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.10%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story

Yahoo Finance • 2 days ago

Trump's new tariffs on pharma, furniture, & trucks: What to know

President Trump announced sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture imports. The duty on pharmaceuticals sits at 100% for patented drugs unless the producer is building a manufacturing plant in the US. White Hou... Full story

Yahoo Finance • 2 days ago

AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive results across all three Phase 3 TEMPO trials reinforce the potential of tavapadon, a no... Full story

Yahoo Finance • 2 days ago

Stocks making the biggest premarket moves: Paccar, Intel, RH, Riot Platforms and more

Check out the companies making the biggest moves in premarket trading: Paccar — The maker of Peterbilt trucks jumped 7% after President Donald Trump said slapped a 25% tariff on imported heavy trucks starting Oct. 1. Intel — The chip compa... Full story

Yahoo Finance • 2 days ago

Eli Lilly, Pfizer Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

Trump’s threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the green as the past few months have already seen a flurry of companies announcing plans to invest in the U.S. Conti... Full story

Yahoo Finance • 3 days ago

J&J: Still a Defensive Giant, or Too Dependent on Pharma?

This article first appeared on GuruFocus. Johnson & Johnson is no longer the diversified consumer-plus-healthcare conglomerate it once was. With the spin-off of Kenvue, nearly two-thirds of sales now come from pharmaceuticals, raising a c... Full story

Yahoo Finance • 3 days ago

Trump’s 100% drug tariffs send pharma stocks lower

[Many different pills on pink background. Prescription pills and vitamins. Flat lay and space for text.] Baurzhan Ibrashev European and Asian pharmaceutical stocks fell Friday after President Donald Trump unveiled sweeping new tariffs, in... Full story

Yahoo Finance • 3 days ago

Dr. Robert Lenz Joins Unlearn as Strategic Advisor

Lenz brings over 20 years of experience in global R&D leadership to guide Unlearn as it scales to deliver next-generation clinical trial solutions SAN FRANCISCO, September 25, 2025--(BUSINESS WIRE)--Unlearn®, a leader in AI solutions for... Full story

Yahoo Finance • 3 days ago

QULIPTA® (atogepant) Now Publicly Reimbursed in Quebec for Chronic Migraine and CGRP Class Review Published

- Expanded access provides an additional treatment option for those with chronic migraine. - AbbVie is dedicated to people living with this debilitating disease and continues its commitment by providing multiple treatments and programs for... Full story

Yahoo Finance • 4 days ago

Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai

New AA (Allergan Aesthetics) Signature™ multimodal treatment approach to be presented at AMWC Dubai following successful launch in 25 countries so far this year. Experts to explore the paradigm shift in medical aesthetics and decode new AA... Full story

Yahoo Finance • 5 days ago

Johnson & Johnson (JNJ) Gains FDA Nod for Subcutaneous Tremfya in Ulcerative Colitis

In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Johnson & Johnson is one of them. Johnson & Johnson (NYSE:JNJ), a global healthcare leader, continues to strengthen its pharmaceutica... Full story

Yahoo Finance • 5 days ago

Genmab upgraded at Guggenheim; says Darzalex related growth concerns are overblown

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images Guggenheim upgraded Genmab (GMAB [https://seekingalpha.com/symbol/GMAB]) to Buy from Neutral on Tuesday, arguing that concerns over the Danish biotech’s growth prospects... Full story

Yahoo Finance • 5 days ago

Amneal Receives U.S. FDA Approval for Bimatoprost Ophthalmic Solution, 0.01%

Amneal Pharmaceuticals LLC Important ophthalmic treatment for patients and expected to be a key growth driver for Amneal’s Affordable Medicines segment BRIDGEWATER, N.J., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“... Full story

Yahoo Finance • 6 days ago

Allergan Aesthetics Announces Expansion of SKINVIVE by JUVÉDERM® into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality

SKINVIVE® to launch in 35 additional markets worldwide from September taking the total to 57 international launches in 2025. Research highlights 94% of people want to improve facial skin quality1*, with deep hydration valued across all age... Full story

Yahoo Finance • 6 days ago

Piper Sandler Reiterates Its ‘Overweight’ Rating on AbbVie Inc. (ABBV) with a $231 PT

AbbVie Inc. (NYSE:ABBV) is one of the 15 Best Stocks to Invest in for Financial Stability.Piper Sandler Reiterates Its ‘Overweight’ Rating on AbbVie Inc. (ABBV) with a $231 PT On September 12, 2025, Piper Sandler reiterated its ‘Overweigh... Full story

Yahoo Finance • 6 days ago

What Is One of the Best Pharmaceutical Stocks to Buy Right Now?

Key Points AbbVie is a sector mainstay that had no fewer than 12 drugs with net sales above $1 billion last year. It also paid a generous dividend. 10 stocks we like better than AbbVie › It isn't easy to find a pharmaceutical company tha... Full story

Yahoo Finance • 6 days ago

Discover 3 Stocks That Might Be Trading Below Their Estimated Fair Value

As U.S. stock indexes reach new highs, with the S&P 500 and Nasdaq posting their third consecutive week of gains, investors are increasingly focused on identifying opportunities that might be trading below their estimated fair value. In th... Full story